Market Share of North America Diabetes Drugs Industry
The North America Diabetes Drugs Market is semi-consolidated with major manufacturers, namely Eli Lilly, Sanofi, Novo Nordisk, AstraZeneca, etc., and other generic players. A major share of the market is held by manufacturers concomitant with strategy-based M&A operations and constantly entering the market to generate new revenue streams and boost the existing ones. These measures taken by the market players will ensure a competitive marketplace, forcing companies to experiment with new technologies.
North America Diabetes Drugs Market Leaders
-
Novo Nordisk
-
Abbott
-
Sanofi
-
Eli Lilly
-
Merck
*Disclaimer: Major Players sorted in no particular order
